Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
221 results found
Nov 17, 2021
Publication
Novavax led
The Lancet Respiratory Medicine
COVID-19, Seasonal influenza
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
Toback, Seth, Galiza, Eva, Cosgrove, Catherine, et al.
Oct 20, 2021
Presentation
COVID-19, Seasonal influenza
Update on Novavax NanoFlu™ vaccine and COVID-19-NanoFlu Combination Vaccine development

Presentation by Vivek Shinde, MD, MPH at the World Vaccine Congress Europe 2021. 

Shinde, Vivek
Oct 12, 2021
Publication
Novavax included/third party
Nature Partner Journals Vaccines
Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine
Singh, Susheel K., Plieskatt, Jordan, Chourasia, Bishwanath K., et al.
Oct 1, 2021
Publication
Novavax led
PLOS ONE
COVID-19
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial
Formica, Neil, Mallory, Raburn, Albert, Gary, et al.
Sep 23, 2021
Publication
Novavax led
The New England Journal of Medicine
COVID-19
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
Heath, Paul T., Galiza, Eva P., Baxter, David N., et al.
Sep 23, 2021
Publication
Novavax led
The Lancet Infectious Diseases
Seasonal influenza, Matrix-M® adjuvant
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
Shinde, Vivek, Cho, Iksung, Plested, Joyce S., et al.
Sep 21, 2021
Publication
Collaborative
Cell Reports Medicine
COVID-19, Matrix-M® adjuvant
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Gorman, Matthew J., Patel, Nita , Guebre-Xabier, Mimi, et al.
Jul 14, 2021
Poster
COVID-19
Accessing Non-Peer-Reviewed Preprint Literature from Various Servers: An Essential Library Resource to Support Vaccine Development During A Global Pandemic

During the Covid-19 pandemic, new information has been changing rapidly and there is significant lag time for new manuscripts to become fully published journal articles. Please download the summary and watch the corresponding video.

Glass, Sharon
Jun 30, 2021
Publication
Novavax led
The New England Journal of Medicine
COVID-19
Safety and Efficacy of the NVX-CoV2373 Covid-19 Vaccine
Heath, Paul T., Galiza, Eva P., Baxter, David N. , et al.
May 25, 2021
Presentation
COVID-19
Novavax COVID-19 Program Update for ISV

Dr. Gregory Glenn's COVID-19 presentation for the International Society for Vaccines (ISV) May 2021.

Glenn, Gregory